Cargando…

Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study

Cardiovascular autonomic neuropathy (CAN) is a debilitating condition occurring among diabetic patients especially those with long duration of disease. Whereas incidences and treatment of CAN has been well described for Western populations, fewer studies have been conducted among the Chinese. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qi, Li, Quanmin, Deng, Wei, Zhao, Dong, Qi, Lin, Huang, Wei, Ma, Li, Li, Hongmei, Li, Yufeng, Lyu, Xiaofeng, Wang, Aihong, Yao, Hebin, Guo, Lixin, Xing, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823192/
https://www.ncbi.nlm.nih.gov/pubmed/31708736
http://dx.doi.org/10.3389/fnins.2019.01144
_version_ 1783464481877131264
author Pan, Qi
Li, Quanmin
Deng, Wei
Zhao, Dong
Qi, Lin
Huang, Wei
Ma, Li
Li, Hongmei
Li, Yufeng
Lyu, Xiaofeng
Wang, Aihong
Yao, Hebin
Guo, Lixin
Xing, Xiaoyan
author_facet Pan, Qi
Li, Quanmin
Deng, Wei
Zhao, Dong
Qi, Lin
Huang, Wei
Ma, Li
Li, Hongmei
Li, Yufeng
Lyu, Xiaofeng
Wang, Aihong
Yao, Hebin
Guo, Lixin
Xing, Xiaoyan
author_sort Pan, Qi
collection PubMed
description Cardiovascular autonomic neuropathy (CAN) is a debilitating condition occurring among diabetic patients especially those with long duration of disease. Whereas incidences and treatment of CAN has been well described for Western populations, fewer studies have been conducted among the Chinese. This study, therefore, aimed to assess the prevalence of CAN among sampled Chinese diabetic patients. Accordingly, 2,048 participants with a history of type 1 diabetes mellitus (T1DM, 73) and type 2 diabetes mellitus (T2DM, 1975) were randomly sampled from 13 hospitals. Patients’ biodata were recorded, and autonomic nervous system function tests performed to aid in the preliminary diagnosis of CAN. The final CAN diagnosis was based on the Ewing’s test in which heart rate variation (HRV) values were evaluated through deep-breathing (DB), lying-to-standing (LS), and Valsalva (V) tests. Systolic blood pressure (SBP) variation values were also evaluated through LS. In the T1DM group, 61.6% patients were diagnosed with CAN and no differences were observed in the baseline and clinical data between this group and those without CAN (P > 0.05). In the T2DM group, 62.6% patients were diagnosed with CAN and statistically significant differences were found between the CAN and non- CAN group with regards to age, duration of diabetes, metformin treatment, retinopathy, and hypertension history (P < 0.05). The most common manifestations of CAN included weakness (28.6%), dizziness (23.4%), frequent urination (19.6%), upper body sweating (18.3%), and nocturia (15.9%). Additionally, duration of disease and age were independent risk factors for CAN in T1DM and T2DM, respectively. On diagnosis, a combination of the V test + LS test provided the highest sensitivity of detecting CAN among T1DM group (sensitivity = 97.6%, AUC = 0.887) while for T2DM category, DB test had the highest sensitivity (83.6%), and maximal AUC (0.856) was found with V test + DB test. The overall prevalence of diabetes with CAN in the study was up to 63%.
format Online
Article
Text
id pubmed-6823192
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68231922019-11-08 Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study Pan, Qi Li, Quanmin Deng, Wei Zhao, Dong Qi, Lin Huang, Wei Ma, Li Li, Hongmei Li, Yufeng Lyu, Xiaofeng Wang, Aihong Yao, Hebin Guo, Lixin Xing, Xiaoyan Front Neurosci Neuroscience Cardiovascular autonomic neuropathy (CAN) is a debilitating condition occurring among diabetic patients especially those with long duration of disease. Whereas incidences and treatment of CAN has been well described for Western populations, fewer studies have been conducted among the Chinese. This study, therefore, aimed to assess the prevalence of CAN among sampled Chinese diabetic patients. Accordingly, 2,048 participants with a history of type 1 diabetes mellitus (T1DM, 73) and type 2 diabetes mellitus (T2DM, 1975) were randomly sampled from 13 hospitals. Patients’ biodata were recorded, and autonomic nervous system function tests performed to aid in the preliminary diagnosis of CAN. The final CAN diagnosis was based on the Ewing’s test in which heart rate variation (HRV) values were evaluated through deep-breathing (DB), lying-to-standing (LS), and Valsalva (V) tests. Systolic blood pressure (SBP) variation values were also evaluated through LS. In the T1DM group, 61.6% patients were diagnosed with CAN and no differences were observed in the baseline and clinical data between this group and those without CAN (P > 0.05). In the T2DM group, 62.6% patients were diagnosed with CAN and statistically significant differences were found between the CAN and non- CAN group with regards to age, duration of diabetes, metformin treatment, retinopathy, and hypertension history (P < 0.05). The most common manifestations of CAN included weakness (28.6%), dizziness (23.4%), frequent urination (19.6%), upper body sweating (18.3%), and nocturia (15.9%). Additionally, duration of disease and age were independent risk factors for CAN in T1DM and T2DM, respectively. On diagnosis, a combination of the V test + LS test provided the highest sensitivity of detecting CAN among T1DM group (sensitivity = 97.6%, AUC = 0.887) while for T2DM category, DB test had the highest sensitivity (83.6%), and maximal AUC (0.856) was found with V test + DB test. The overall prevalence of diabetes with CAN in the study was up to 63%. Frontiers Media S.A. 2019-10-25 /pmc/articles/PMC6823192/ /pubmed/31708736 http://dx.doi.org/10.3389/fnins.2019.01144 Text en Copyright © 2019 Pan, Li, Deng, Zhao, Qi, Huang, Ma, Li, Li, Lyu, Wang, Yao, Guo and Xing. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Pan, Qi
Li, Quanmin
Deng, Wei
Zhao, Dong
Qi, Lin
Huang, Wei
Ma, Li
Li, Hongmei
Li, Yufeng
Lyu, Xiaofeng
Wang, Aihong
Yao, Hebin
Guo, Lixin
Xing, Xiaoyan
Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title_full Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title_fullStr Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title_full_unstemmed Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title_short Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study
title_sort prevalence and diagnosis of diabetic cardiovascular autonomic neuropathy in beijing, china: a retrospective multicenter clinical study
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823192/
https://www.ncbi.nlm.nih.gov/pubmed/31708736
http://dx.doi.org/10.3389/fnins.2019.01144
work_keys_str_mv AT panqi prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT liquanmin prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT dengwei prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT zhaodong prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT qilin prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT huangwei prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT mali prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT lihongmei prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT liyufeng prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT lyuxiaofeng prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT wangaihong prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT yaohebin prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT guolixin prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy
AT xingxiaoyan prevalenceanddiagnosisofdiabeticcardiovascularautonomicneuropathyinbeijingchinaaretrospectivemulticenterclinicalstudy